{
  "actions": [
    {
      "acted_at": "2020-05-12",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2020-05-12",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr6839-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "G000588",
      "district": "16",
      "name": "Gonzalez, Anthony",
      "original_cosponsor": true,
      "sponsored_at": "2020-05-12",
      "state": "OH",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-05-12",
  "number": "6839",
  "official_title": "To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr6800-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": null,
  "sponsor": {
    "bioguide_id": "S001209",
    "district": "7",
    "name": "Spanberger, Abigail Davis",
    "state": "VA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-05-12",
  "subjects": [
    "Blood and blood diseases",
    "Cardiovascular and respiratory health",
    "Congressional oversight",
    "Drug safety, medical device, and laboratory regulation",
    "Emergency medical services and trauma care",
    "Government studies and investigations",
    "Health",
    "Health facilities and institutions",
    "Infectious and parasitic diseases",
    "Medical tests and diagnostic methods",
    "State and local government operations"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2020-05-12",
    "date": "2020-06-11T16:33:11Z",
    "text": "This bill requires the Government Accountability Office (GAO) to report on diagnostic tests to diagnose COVID-19 (i.e., coronavirus disease 2019) or detect the virus that causes the disease. Specifically, the report must describe the response of, among others, laboratories, diagnostic test manufacturers, and government entities with respect to the development, regulatory evaluation, and deployment of diagnostic tests. The GAO must also assess standards, guidance, clinical processes, and intergovernmental coordination related to COVID-19 testing."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.",
      "type": "official"
    }
  ],
  "updated_at": "2023-01-11T13:42:56Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr6839.xml"
}